Policy & Regulation

19 articles

Policy & Regulation

NIH BRAIN Initiative publishes 10-year Neuroscience Research Roadmap in Neuron, anchoring next decade of US federal neuroscience around four Innovation Domains

NIH BRAIN Initiative Director John Ngai and Acting NINDS Director Amy Bany Adams jointly announced the formal publication of the BRAIN Initiative's 10-year Neuroscience Research Roadmap on 15 May 2026, with a Director's Message and a paper in Neuron. The roadmap, finalised in August 2025, organises the next decade of US federally-funded neuroscience around four Innovation Domains: BRAIN Knowledgebase, Precision Molecular Circuit Therapies, Accelerating Human Neuroscience, and BRAIN NeuroAI.

May 22

Policy & Regulation

Vermont signs H.814 into law, becoming the fifth US state with a neural rights statute

Governor Phil Scott signed H.814 into law on 18 May 2026, making Vermont the fifth US state with neural data privacy legislation on the books after Colorado, California, Montana, and Connecticut. The enacted text is the 6-page version of a bill that originally cleared the House at 32 pages; the consent requirement and private right of action did not survive the Senate amendment process. Effective 1 July 2026.

May 21

Policy & Regulation

Inspire takes the first quantified WISeR hit as Medicare bifurcates its neuromodulation posture

Inspire's Q1 2026 print attributes a combined $120 to $150 million FY26 hit to WISeR plus coding uncertainty, six sell-side analysts cut targets through 7 May, and NeuroPace just received a 43% to 47% Medicare reimbursement increase on the same rule cycle.

May 8

Policy & Regulation

Order 818 takes effect: BCI joins gene and cell therapy on China's parallel commercial track

The State Council's biomedical-new-technologies regulation took effect 1 May 2026, letting Chinese hospitals charge for BCI commercially after a translation approval. Foreign-invested enterprises remain locked out.

May 8

Policy & Regulation

Vermont H.814 clears Senate, neural rights statute awaits Governor Scott

The Senate passed H.814 in concurrence with the House on 6 May. What now sits with Governor Scott is a 6-page recognition statute, with the enforcement layer stripped in committee.

May 7

Policy & Regulation

EU AI Act enforcement for BCI medical devices delayed to August 2028 in Council-Parliament deal

The provisional agreement reached on 7 May 2026 pushes high-risk AI obligations by 16 to 24 months, including the rules that capture Class IIb and Class III medical-device BCIs.

May 7

Policy & Regulation

Neuroethics 2026 opens at Stanford as the field meets its first commercial moment

The International Neuroethics Society convenes across Stanford, Lucca and Stellenbosch as the BCI sector absorbs $960 million in Q1, a Chinese reimbursement benchmark of US$900 per implant, and 20 Neuralink patients — and the governance window is narrowing.

Apr 15

Policy & Regulation

GAO Names Neural Implants Among Three Emerging Priorities for Congress

A Government Accountability Office report warns that the FDA has no framework for augmentation uses of brain-computer interfaces, even as military and commercial applications advance.

Apr 6

Policy & Regulation

China Elevates BCI to Government Work Report as Clinical Programmes Expand

Brain-computer interfaces appeared in China's government work report for the first time during the 2026 'two sessions,' placing the technology alongside quantum computing and 6G as a national strategic priority.

Apr 4

Policy & Regulation

US States Build Patchwork of Neural Data Privacy Laws as BCI Market Accelerates

Four states now classify brain data as sensitive personal information, with at least seven more bills advancing in 2026 — but definitions vary widely and no federal standard is in sight.

Apr 3

Policy & Regulation

Asilomar Summit Convenes to Build Governance Toolkit for Neurotechnology

A four-day invitation-only summit modelled on the landmark 1975 DNA conference brings together neuroethicists, investors, and policymakers to create practical governance tools for the BCI industry.

Mar 29

Policy & Regulation

UK Funds £1 Million Philosophy of Neurotechnology Research Lab

Four philosophers at Glasgow and Oxford will lead a new interdisciplinary lab examining the ethical and epistemological implications of brain-computer interfaces.

Mar 28

Policy & Regulation

FDA's One-Trial Default Lands Just as BCI Companies Approach Pivotal Studies

The agency's new policy ending the two-trial requirement was written for drugs, but brain implant makers watching Synchron, Neuralink, and Paradromics navigate FDA are asking whether the same logic could eventually ease their path.

Mar 22

Policy & Regulation

Medicare Has No Plan for Brain-Computer Interfaces

A Health Affairs analysis argues that CMS needs a dedicated coverage pathway for implantable BCIs before the technology outpaces the reimbursement system that patients depend on.

Mar 21

Policy & Regulation

South Korea Launches National BCI Strategy With Seven Moonshot Missions

The Ministry of Science and ICT has designated brain-computer interfaces as a core future industry, setting seven mission areas from paralysis treatment to defence applications, with full-scale project funding beginning in 2027.

Mar 18

Policy & Regulation

The FDA Just Quietly Redrew the Line Between Wellness Device and Medical Device

New guidance expands the 'general wellness' exemption for wearables and loosens oversight of AI clinical decision tools — with major implications for every company building consumer neurotechnology.

Mar 7

Policy & Regulation

India Bets on Brain-Computer Interfaces with IISc Moonshot and Policy Push

As China and the US race ahead in neurotechnology, India's premier research institute launches an AI brain co-processor project while analysts urge strategic preparation.

Mar 7

Policy & Regulation

China Designates BCIs a Strategic Industry with 2027 Breakthrough Targets

Seven Chinese government bodies have released guidelines establishing a roadmap for brain-computer interface development, with BCI procedures now receiving medical insurance reimbursement in parts of the country.

Mar 5

Policy & Regulation

EU Proposes Landmark 'Neuro-Rights' Framework: First Major Regulatory Push for Brain Data Privacy

European Commission outlines sweeping rules protecting cognitive liberty and neural data, setting global standard for brain-computer interface regulation.

Feb 22

Stay Ahead of the Curve

Get the latest BCI news, breakthroughs, and market moves delivered to your inbox.

No spam. One-click unsubscribe. We respect your privacy.